DFFVX
Price
$34.85
Change
+$0.18 (+0.52%)
Updated
Jul 3 closing price
Net Assets
13.39B
RYVFX
Price
$9.96
Change
+$0.08 (+0.81%)
Updated
Jul 3 closing price
Net Assets
97.84M
Interact to see
Advertisement

DFFVX vs RYVFX

Header iconDFFVX vs RYVFX Comparison
Open Charts DFFVX vs RYVFXBanner chart's image
DFA US Targeted Value I
Price$34.85
Change+$0.18 (+0.52%)
VolumeN/A
Net Assets13.39B
Royce Small-Cap Value Service
Price$9.96
Change+$0.08 (+0.81%)
VolumeN/A
Net Assets97.84M
DFFVX vs RYVFX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
DFFVX vs. RYVFX commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DFFVX is a Buy and RYVFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
DFFVX has more cash in the bank: 13.4B vs. RYVFX (97.8M). DFFVX pays higher dividends than RYVFX: DFFVX (1.63) vs RYVFX (0.95). DFFVX was incepted earlier than RYVFX: DFFVX (25 years) vs RYVFX (24 years). RYVFX (1.60) is less costly to investors than DFFVX (0.30). RYVFX is a more actively managed with annual turnover of: 43.00 vs. DFFVX (7.00). DFFVX has a lower initial minimum investment than RYVFX: DFFVX (0) vs RYVFX (2000). DFFVX annual gain was more profitable for investors over the last year : 11.79 vs. RYVFX (1.67). DFFVX return over 5 years is better than : 116.56 vs. RYVFX (53.30).
DFFVXRYVFXDFFVX / RYVFX
Total Expense Ratio0.291.4919%
Annual Report Gross Expense Ratio0.301.6019%
Fund Existence25 years24 years-
Gain YTD2.331-0.500-467%
Front LoadN/AN/A-
Min. Initial Investment02000-
Min. Initial Investment IRAN/AN/A-
Net Assets13.4B97.8M13,701%
Annual Yield % from dividends1.630.95172%
Returns for 1 year11.791.67706%
Returns for 3 years37.5121.21177%
Returns for 5 years116.5653.30219%
Returns for 10 years62.84-10.31-609%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LGOAX41.250.42
+1.03%
Patient Opportunity A
ESAGX11.980.11
+0.93%
Ashmore Emerging Markets Equity ESG A
MASMX10.720.05
+0.47%
Madison Small Cap A
DEMCX24.180.03
+0.12%
Macquarie Emerging Markets C
ARIFX12.720.01
+0.08%
Aristotle International Eq I